eps.co.jpの競合サイトトップ10

novotech-cro.com

Triple-Negative Breast Cancer (TNBC) is a highly aggressive and heterogeneous subtype of breast cancer This FAQ section explores its incidence, ongoing trials, innovative drug therapies, and their impact on patient outcomes. 1. What makes TNBC different from other breast cancer subtypes?

cmicgroup.com

シミックグループは、日本におけるCRO（医薬品開発支援）のパイオニアとして、グループ独自の事業モデル「PVC: Pharmaceutical Value Creator」を展開し、開発から製造、営業・マーケティングなど、製薬企業のバリューチェーンをすべて支援できる体制を整えています。

ppdi.com

Discover PPD's vaccine development and clinical trial management strategies that enable science and society to come together to protect public health.

inizio.com

Learn more about Inizio's Data Privacy Framework Policy and how it collects, use, and discloses certain personally identifiable information.

allucent.com

Pharmacokinetic studies aim to understand how drugs move throughout & interact with your body (ADME) to provide safe & effective drug doses.

celerion.com

Celerion is committed to implementing innovative strategies with applied translational medicine to gain insights on early drug development decisions. We provide vital expertise and experience in a large clinical capacity to ensure our clients are getting their product to the market faster.

crownbio.com

Partner with Crown Bioscience for CRO consulting services that bridge preclinical and clinical research. Our experts accelerate drug development success.

inotiv.com

Inotiv has over 1,200 devoted employees in more than 20 locations across North America and Europe who provide our customers with mission-critical products and services to enable their critical research.

q2labsolutions.com

We provide trusted immunogenicity risk assessment services, including in vitro methods, in silico methods, and MHC-associated peptide proteomics (MAPPS).

nuvisan.com

fully integrated cro/cdmo, with a 40-year track record of serving pharmaceutical and biotech companies.